Unifaith Biotech

Unifaith Biotech is an Indian pharmaceutical company founded in 2020 and headquartered in New Delhi. The company specializes in the development, marketing, and distribution of high-quality branded generic products, with a primary focus on critical care, anti-infectives, oncology, and gastroenterology. Its portfolio includes a wide range of injectable and oral medications, such as the antibiotic Merfaith and the specialty treatment Foxpressin. Unifaith Biotech currently sources its products from WHO-GMP certified partners while actively working toward establishing its own state-of-the-art manufacturing facilities. The company aims to become a leading player in the Indian pharmaceutical market and expand its reach to global markets. It is committed to providing affordable and effective healthcare solutions through continuous innovation and strategic decision-making.